Image

Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.

Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this study is to analyse contiguous dental implants and its peri-implant status depending on different inter-implant distances.

Description

The present research project has been designed as a multicentric cross-sectional study. The STROBE guidelines have been followed in the design of this observational study.

Ethical issues The study will be performed after the approval of the Ethics Committee of the Universitat Internacional de Catalunya (UIC) and Faculdade de Medicina Dentária da Universidade de Lisboa (FMDUL) and will be intended to be registered in clinicaltrials.gov. Also, this research will be conducted according to the principles outlined in the Declaration of Helsinki (revised, amended, and clarified in 2013). In addition, all study participants will provide written informed consent before participating in the study.

Study population Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).

Criteria for subject selection will be as follows:

  • The patient must be ≥18 years of age and systemically healthy;
  • Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
  • Screw or cemented-retained prosthesis;
  • Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
  • No implant mobility.

Moreover, the exclusion criteria will be the following:

  • Pregnant and lactating women;
  • Patients who have taken systemic antibiotics during the 3 months prior to the examination;
  • Patients being treated with drugs that may induce a gingival overgrowth;
  • Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
  • Patients who have received mechanical debridement during the 3 months prior to the exam;
  • Patients who have received surgical treatment for peri-implantitis;
  • Psychophysical inability to carry out study procedures.

Eligibility

Inclusion Criteria:

  • The patient must be ≥18 years of age and systemically healthy;
  • Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
  • Screw or cemented-retained prosthesis;
  • Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
  • No implant mobility.

Exclusion Criteria:

  • Pregnant and lactating women;
  • Patients who have taken systemic antibiotics during the 3 months prior to the examination;
  • Patients being treated with drugs that may induce a gingival overgrowth;
  • Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
  • Patients who have received mechanical debridement during the 3 months prior to the exam;
  • Patients who have received surgical treatment for peri-implantitis;
  • Psychophysical inability to carry out study procedures.

Study details
    Peri-implant Mucositis
    Peri-Implantitis

NCT06364982

Universitat Internacional de Catalunya

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.